Monocrotaline pyrrole interacts with actin and increases thrombin- mediated permeability in pulmonary artery endothelial cells

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 138-144

  Wilson, D W ^a   Lame M W ^a   Dunston, S K ^a   Taylor, D W ^a   Segall, H J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALBUMIN; CALCIUM ION; CARBON 14; EVANS BLUE; MONOCROTALINE PYRROLE; THROMBIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; AUTORADIOGRAPHY; CALCIUM CELL LEVEL; CATTLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; COVALENT BOND; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

EID: 0031738781     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8488     Document Type: Article

References (39)

1. Allen, J. R., and Carstens, L. A. (1970). Pulmonary vascular occlusions initiated by endothelial lysis in monocrotaline-intoxicated rats. Exp. Mol. Pathol. 13(159), 159-171.
2. Anderson, J. M., and Van Itallie, C. M. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269, G467-475.
3. Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., Koerner, S. K., Langleben, D., Keller, C. A., Uretsky, B. F., and Clayton, L. M. (1996). A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group. N. Engl. J. Med. 334, 296-302.
4. Bruner, L. H., Carpenter, L. J., Hamlow, P., and Roth, R. A. (1986). Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol. Appl. Pharmacol. 85, 416-427.
5. Fuster, V., Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., and Frye, R. L. (1984). Primary pulmonary hypertension: Natural history and the importance of thrombosis. Circulation 70, 580-587.
6. Garcia, J. G. N., Verin, A., and Schaphorst, K. L. (1996). Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin. Thromb. Hemostasis 22, 309-315.
7. Hayashi, Y., Kokubo, T., Takahashi, M., Furukawa, F., Otsuka, H., and Hashimoto, K. (1984). Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in rats. Toxicol. Lett. 21(65), 65-71.
8. Hilliker, K. S., Bell, T. G., and Roth, R. A. (1982). Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am. J. Physiol. 242, H573-579.
9. Hoorn, C. M., Wagner, J. G., and Roth, R. A. (1993). Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium. Toxicol. Appl. Pharmacol. 120, 281-287.
10. Kay, J. M., and Heath, D. (1970). Crotalaria spectabilis, the Pulmonary Hypertension Plant. Charles C Thomas, Springfield IL.
11. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
12. Lafranconi, W. M., and Huxtable, R. J. (1984). Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem. Pharmacol. 33, 2479-2484.
13. Lalich, J., Johnson, W. D., Raczniak, T. J., and Shumaker, R. C. (1977). Fibrin Thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats. Arch. Pathol. Lab. Med. 101(69), 69-73.
14. Lamé, M. W., Morin, D., Jones, A. D., Segall, H. J., and Wilson, D. W. (1990). Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol. Lett. 51, 321-329.
15. Lamé, M. W., Jones, A. D., Morin, D., Wilson, D. W., and Segall, H. J. (1997). Association of dehydromonocrotaline with rat red blood cells. Chem. Res. Toxicol. 10, 694-701.
16. Lopes, A. A., Maeda, N. Y., Almeida, A., Jaeger, R., Ebaid, M., and Chamone, D. F. (1993). Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology 44, 701-706.
17. Lum, H., and Malik, A. B. (1994). Regulation of vascular endothelial barrier function. Am. J. Physiol. 267, L223-241.
18. Lum, H., and Malik, A. B. (1996). Mechanisms of increased endothelial permeability. Can. J. Physiol. Pharmacol. 74, 787-800.
19. Nakajima-Iijima, S., Hamada, H., Reddy, P., and Kakunaga, T. (1985). Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sciences 82, 6133-6137.
20. Pan, L. C., Lamé, M. W., Morin, D., Wilson, D. W., and Segall, H. J. (1991). Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations. Toxicol. Appl. Pharmacol. 110, 336-346.
21. 14C-monocrotaline in rat liver microsomes. J. Biochem. Toxicol. 12, 157-166.
22. Reindel, J. F., and Roth, R. A. (1991). The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells. Am. J. Pathol. 138, 707-716.
23. Roth, R. A., and Ganey, P. E. (1988). Platelets and the puzzles of pulmonary pyrrolizidine poisioning. Toxicol. Appl. Pharmacol. 93, 463-471.
24. Schultze, A. E., Wagner, J. G., and Roth, R. A. (1991). An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 109, 421-431.
25. Schultze, A. E., and Roth, R. A. (1993). Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 121(1), 129-137.
26. Taylor, D. W., Wilson, D. W., Lamé, M. W., Dunston, S. D., Jones, A. D., and Segall, H. J. (1996a). Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. 143, 196-204.
27. Taylor, D. W., Wilson, D. W., Lamé, M. W., Dunston, S. D., and Segall, H. J. (1996b). Changes in actin polymerization in pulmonary vascular endothelial cells is associated with exposure to monocrotaline pyrrole. Am. J. Resp. Crit. Care Med. 153, A193.
28. Thomas, H. C., Lamé, M. W., Wilson, D. W., and Segall, H. J. (1996). Cell cycle alteration associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA. Toxicol. Appl. Pharmacol. 141, 319-329.
29. Thomas, H. C., Lamé, M. W., Dunston, S. K., Segall, H. J., and Wilson, D. W. (1998a). Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. (in press).
30. Thomas, H. C., Lamé, M. W., Morin, D., Wilson, D. W., and Segall, H. J. (1998b). Prolonged cell cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole treated pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. (in press).
31. Valdivia, E., Sonnad, J., Hayashi, Y., and Lalich, J. J. (1967). Experimental interstitial pulmonary edema. Angiology 18, 378-383.
32. Verin, A. D., Patterson, C. E., Day, M. A., and Garcia, J. G. (1995). Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am. J. Physiol. 269, L99-108.
33. Voelkel, N. F., and Tuder, R. M. (1995). Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur. Respir. J. 8, 2129-2138.
34. Wagenvoort, C. A., and Mulder, P. G. (1993). Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? Chest 103, 844-849.
35. Watts, R. G., and Howard, T. H. (1993). Mechanisms for actin reorganization in chemotactic factor-activated polymorphonuclear leukocytes. Blood 10, 2750-2757.
36. Weibel, E. R. (1979). Stereological Methods: Vol. 1, Practical Methods for Biological Morphometry. Academic Press, New York.
37. Wilson, D. W., Segall, H. J., Pan, L., and Dunston, S. K. (1989). Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline treated rats. Microvasc. Res. 38, 57-80.
38. Wilson, D. W., Segall, H. J., Pan, L. C., Lamé, M. W., Estep, J. E., and Morin, D. (1992). Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 22, 307-325.
39. Zhou, X., Hurst, R., Templeton, D., and Whiteside, C. (1995). High glucose alters actin assembly in gomerular mesangial and epithelial cells. Lab. Invest. 73, 372-383.